Co-Founder, CEO & Chairman
Douglas Falk, MS, co-founded and joined Vita Therapeutics, Inc. as Chief Executive Officer in 2019. Prior he spent 6 years in the investment world with a particular focus in biotechnology at Brown Advisory, where he was a principal, Merrill Lynch, and Lazard. Mr. Falk was also involved in the formation of OptoStem and currently sits on the board of directors. In addition, Mr. Falk currently sits on the Board of Directors for the Johns Hopkins Biotechnology Investment Group. Mr. Falk received his M.S. from Johns Hopkins University in biotechnology and his BA from Goucher College in Economics and Business Management.